Use of hormone replacement therapy

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7058.686 (Published 14 September 1996) Cite this as: BMJ 1996;313:686

Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive

  1. Karen Mckinney, Senior registrar
  1. Department of Obstetrics and Gynaecology, Queen's University of Belfast, Institute of Clinical Science, Belfast, BT7 1NN

    EDITOR,—As a female doctor who has a specialist interest in the menopause and hormone replacement therapy, I was interested to read Elizabeth H Price and Helen Kaye Little's letter about hormone replacement therapy.1 I agree that women need to be informed about the risks associated with such treatment. I disagree, however, with the authors' statements about the increased risk of breast cancer.

    The epidemiological evidence on the effect of combined treatment with …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial